GMAB logo

Genmab A/S (GMAB) EBIT

Annual EBIT

$822.34 M
-$165.17 M-16.73%

December 31, 2023

Summary

Performance

1-Year Change

-16.73%

3-Year Change

-9.25%

5-Year Change

+222.04%

15-Year Change

+280.99%

GMAB EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.86%
GMAB annual earnings before interest & taxes is higher than 94.86% of companies in Healthcare sector

High & Low

All-time High

$987.51 M
GMAB annual earnings before interest & taxes is currently -16.73% below its historical high of $987.51 million

3-Year Low

$625.50 M
GMAB annual earnings before interest & taxes is currently +31.47% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GMAB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 8, 2025
GMAB next annual earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

Annual Revenue

$2.39 B
GMAB annual revenue is $2.39 billion

Annual Net Income

$631.85 M
GMAB annual net profit is $631.85 million

Annual EBITDA

$865.17 M
GMAB annual EBITDA is $865.17 million

Annual EPS

$0.96
GMAB annual earnings per share is $0.96

Quarterly EBIT

$255.98 M
-$53.78 M-17.36%

September 1, 2024

Summary

Performance

3-Month Change

-17.36%

1-Year Change

-34.57%

3-Year Change

+552.59%

5-Year Change

+552.59%

GMAB Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.66%
GMAB quarterly earnings before interest & taxes is higher than 94.66% of companies in Healthcare sector

High & Low

All-time High

$670.32 M
GMAB quarterly earnings before interest & taxes is currently -61.81% below its historical high of $670.32 million

3-Year Low

$39.23 M
GMAB quarterly earnings before interest & taxes is currently +552.59% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

Quarterly Revenue

$816.44 M
GMAB quarterly revenue is $816.44 million

Quarterly Net Income

$186.57 M
GMAB quarterly net profit is $186.57 million

Quarterly EBITDA

$272.49 M
GMAB quarterly EBITDA is $272.49 million

Quarterly EPS

$0.29
GMAB quarterly earnings per share is $0.29

TTM EBIT

$958.87 M
-$135.24 M-12.36%

September 1, 2024

Summary

Performance

3-Month Change

-12.36%

1-Year Change

+26%

3-Year Change

+4.28%

5-Year Change

+4.28%

GMAB TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.08%
GMAB TTM earnings before interest & taxes is higher than 95.08% of companies in Healthcare sector

High & Low

All-time High

$1.23 B
GMAB TTM earnings before interest & taxes is currently -22.13% below its historical high of $1.23 billion

3-Year Low

$556.33 M
GMAB TTM earnings before interest & taxes is currently +72.36% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

TTM Revenue

$2.89 B
GMAB TTM revenue is $2.89 billion

TTM Net Income

$684.26 M
GMAB TTM net profit is $684.26 million

TTM EBITDA

$983.75 M
GMAB TTM EBITDA is $983.75 million

TTM EPS

$1.05
GMAB TTM earnings per share is $1.05

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

$822.34 M
GMAB annual earnings before interest & taxes is $822.34 million

Annual Revenue

$2.39 B
GMAB annual revenue is $2.39 billion

Annual Cost Of Goods Sold

$32.81 M
GMAB annual cost of goods sold is $32.81 million

Annual Operating Expenses

$1.59 B
GMAB annual total operating expenses is $1.59 billion

GMAB EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.7%-34.6%+26.0%
3 y3 years-9.3%+552.6%+4.3%
5 y5 years+222.0%+552.6%+4.3%

GMAB EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.7%+31.5%-42.3%+552.6%-12.4%+72.4%
5 y5-year-16.7%+91.4%-61.8%+552.6%-22.1%+120.1%
alltimeall time-16.7%+800.4%-61.8%+893.4%-22.1%+1527.6%

Genmab A/S EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
$255.98 M(-17.4%)
$958.87 M(-12.4%)
Jun 2024
-
$309.76 M(+23.4%)
$1.09 B(+5.7%)
Mar 2024
-
$250.97 M(+76.5%)
$1.04 B(+25.7%)
Dec 2023
$822.34 M(-16.7%)
$142.16 M(-63.7%)
$823.85 M(+8.3%)
Sep 2023
-
$391.22 M(+55.7%)
$761.01 M(-6.5%)
Jun 2023
-
$251.24 M(+540.5%)
$813.57 M(-11.5%)
Mar 2023
-
$39.23 M(-50.5%)
$919.52 M(-5.5%)
Dec 2022
$987.51 M(+57.9%)
$79.32 M(-82.1%)
$973.22 M(-5.8%)
Sep 2022
-
$443.79 M(+24.2%)
$1.03 B(+33.2%)
Jun 2022
-
$357.18 M(+284.4%)
$775.44 M(+39.4%)
Mar 2022
-
$92.92 M(-33.2%)
$556.33 M(-19.9%)
Dec 2021
$625.50 M(-31.0%)
$139.05 M(-25.4%)
$694.73 M(+7.8%)
Sep 2021
-
$186.28 M(+34.9%)
$644.43 M(-4.8%)
Jun 2021
-
$138.08 M(-40.3%)
$676.66 M(-44.0%)
Mar 2021
-
$231.33 M(+160.7%)
$1.21 B(+17.4%)
Dec 2020
$906.15 M(+110.9%)
$88.74 M(-59.4%)
$1.03 B(-16.3%)
Sep 2020
-
$218.52 M(-67.4%)
$1.23 B(+10.1%)
Jun 2020
-
$670.32 M(+1175.4%)
$1.12 B(+136.1%)
Mar 2020
-
$52.56 M(-81.9%)
$473.57 M(+8.7%)
Dec 2019
$429.74 M(+68.3%)
$289.97 M(+175.3%)
$435.62 M(+63.5%)
Sep 2019
-
$105.32 M(+309.4%)
$266.46 M(+38.5%)
Jun 2019
-
$25.73 M(+76.1%)
$192.36 M(+2.2%)
Mar 2019
-
$14.61 M(-87.9%)
$188.27 M(-12.8%)
Dec 2018
$255.35 M(+18.3%)
$120.80 M(+287.0%)
$215.84 M(+8.1%)
Sep 2018
-
$31.22 M(+44.3%)
$199.66 M(+12.4%)
Jun 2018
-
$21.64 M(-48.7%)
$177.66 M(-24.5%)
Mar 2018
-
$42.18 M(-59.7%)
$235.34 M(+20.0%)
Dec 2017
$215.84 M(+28.5%)
$104.63 M(+1035.6%)
$196.10 M(-4.5%)
Sep 2017
-
$9.21 M(-88.4%)
$205.25 M(-8.4%)
Jun 2017
-
$79.31 M(+2587.9%)
$224.05 M(+34.8%)
Mar 2017
-
$2.95 M(-97.4%)
$166.26 M(+0.3%)
Dec 2016
$168.02 M(+49.1%)
$113.77 M(+306.1%)
$165.72 M(+49.3%)
Sep 2016
-
$28.02 M(+30.2%)
$111.00 M(+6.5%)
Jun 2016
-
$21.52 M(+791.0%)
$104.23 M(+17.7%)
Mar 2016
-
$2.42 M(-95.9%)
$88.54 M(-21.2%)
DateAnnualQuarterlyTTM
Dec 2015
$112.72 M(+109.7%)
$59.04 M(+177.9%)
$112.32 M(+75.1%)
Sep 2015
-
$21.25 M(+264.1%)
$64.13 M(-5.2%)
Jun 2015
-
$5.84 M(-77.7%)
$67.65 M(+20.8%)
Mar 2015
-
$26.19 M(+141.4%)
$55.99 M(+15.9%)
Dec 2014
$53.76 M(+339.3%)
$10.85 M(-56.2%)
$48.30 M(+1.4%)
Sep 2014
-
$24.77 M(-525.2%)
$47.66 M(+100.9%)
Jun 2014
-
-$5.83 M(-131.5%)
$23.72 M(-10.2%)
Mar 2014
-
$18.50 M(+81.3%)
$26.41 M(+99.7%)
Dec 2013
$12.24 M(-163.6%)
$10.20 M(+1121.9%)
$13.23 M(>+9900.0%)
Sep 2013
-
$835.10 K(-126.7%)
$114.50 K(-102.2%)
Jun 2013
-
-$3.13 M(-158.9%)
-$5.30 M(-38.6%)
Mar 2013
-
$5.32 M(-282.9%)
-$8.62 M(-64.3%)
Dec 2012
-$19.23 M(-50.5%)
-$2.91 M(-36.5%)
-$24.15 M(-4.8%)
Sep 2012
-
-$4.58 M(-29.1%)
-$25.35 M(-20.2%)
Jun 2012
-
-$6.45 M(-36.8%)
-$31.76 M(-16.3%)
Mar 2012
-
-$10.21 M(+148.2%)
-$37.94 M(-2.9%)
Dec 2011
-$38.82 M(+163.3%)
-$4.11 M(-62.6%)
-$39.05 M(+6.5%)
Sep 2011
-
-$10.98 M(-13.0%)
-$36.65 M(-1221.2%)
Jun 2011
-
-$12.63 M(+11.5%)
$3.27 M(-2644.1%)
Mar 2011
-
-$11.33 M(+560.0%)
-$128.50 K(-99.2%)
Dec 2010
-$14.74 M(-51.0%)
-$1.72 M(-105.9%)
-$16.04 M(-163.1%)
Sep 2010
-
$28.94 M(-280.6%)
$25.43 M(-179.5%)
Jun 2010
-
-$16.03 M(-41.2%)
-$31.99 M(-33.7%)
Mar 2010
-
-$27.24 M(-168.5%)
-$48.23 M(+75.9%)
Dec 2009
-$30.11 M(-74.4%)
$39.75 M(-239.6%)
-$27.41 M(-59.2%)
Sep 2009
-
-$28.48 M(-11.7%)
-$67.17 M(+73.6%)
Jun 2009
-
-$32.27 M(+402.2%)
-$38.69 M(+502.2%)
Mar 2009
-
-$6.42 M
-$6.42 M
Dec 2008
-$117.41 M(+92.3%)
-
-
Dec 2007
-$61.05 M(-17.1%)
-
-
Dec 2006
-$73.63 M(+12.4%)
-
-
Dec 2005
-$65.51 M(-181.0%)
-
-
Dec 2004
$80.92 M(+29.4%)
-
-
Dec 2003
$62.55 M(-15.2%)
-
-
Dec 2002
$73.73 M
-
-

FAQ

  • What is Genmab A/S annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Genmab A/S?
  • What is Genmab A/S annual EBIT year-on-year change?
  • What is Genmab A/S quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Genmab A/S?
  • What is Genmab A/S quarterly EBIT year-on-year change?
  • What is Genmab A/S TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Genmab A/S?
  • What is Genmab A/S TTM EBIT year-on-year change?

What is Genmab A/S annual earnings before interest & taxes?

The current annual EBIT of GMAB is $822.34 M

What is the all time high annual EBIT for Genmab A/S?

Genmab A/S all-time high annual earnings before interest & taxes is $987.51 M

What is Genmab A/S annual EBIT year-on-year change?

Over the past year, GMAB annual earnings before interest & taxes has changed by -$165.17 M (-16.73%)

What is Genmab A/S quarterly earnings before interest & taxes?

The current quarterly EBIT of GMAB is $255.98 M

What is the all time high quarterly EBIT for Genmab A/S?

Genmab A/S all-time high quarterly earnings before interest & taxes is $670.32 M

What is Genmab A/S quarterly EBIT year-on-year change?

Over the past year, GMAB quarterly earnings before interest & taxes has changed by -$135.24 M (-34.57%)

What is Genmab A/S TTM earnings before interest & taxes?

The current TTM EBIT of GMAB is $958.87 M

What is the all time high TTM EBIT for Genmab A/S?

Genmab A/S all-time high TTM earnings before interest & taxes is $1.23 B

What is Genmab A/S TTM EBIT year-on-year change?

Over the past year, GMAB TTM earnings before interest & taxes has changed by +$197.86 M (+26.00%)